Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2257
https://www.valueinhealthjournal.com/article/S1098-3015(16)33623-3/fulltext
Title : Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33623-3&doi=10.1016/j.jval.2016.09.2257
First page : A741
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2143
Categories :
Tags :
Regions :
ViH Article Tags :